Phase-II-study with bendamustine/carboplatin in untreated patients with extensive disease small cell lung cancer.

被引：0
|
作者：
Koester, W
Stamatis, G
Niederle, N
Heider, A
Avramidis, K
Wilke, H
Stahl, M
机构：
[1] Kliniken Essen Mitte, Essen, Germany
[2] Ruhrlandklin, Essen, Germany
[3] Dept Hematol & Oncol, Leverkusen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7265
引用
收藏
页码：682S / 682S
页数：1
相关论文
共 50 条
  • [41] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Kallab, AM
    Nalamolu, Y
    Dainer, PM
    Jillella, AP
    MEDICAL ONCOLOGY, 2005, 22 (02) : 145 - 151
  • [42] A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Andre Michel Kallab
    Yasolatha Nalamolu
    Paul Maclyn Dainer
    Anand Prasad Jillella
    Medical Oncology, 2005, 22 : 145 - 151
  • [43] Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study
    Gridelli, C
    Rossi, A
    Scognamiglio, F
    Guida, C
    Fiore, F
    Gatani, T
    Scoppa, G
    Pergola, M
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4755 - 4758
  • [44] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
    Fukuda, M
    Oka, M
    Soda, H
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Kuba, M
    Takatani, H
    Tsurutani, J
    Nakamura, Y
    Kasai, T
    Inoue, Y
    Soejima, Y
    Kohno, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 573 - 577
  • [45] Phase II study of combination therapy with liposomal doxorubicin and carhoplatin in patients with previously untreated small cell lung cancer.
    Rapoport, BL
    Slabber, C
    Vorobiof, DA
    Alberts, AS
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 703S - 703S
  • [46] Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer
    Minoru Fukuda
    Mikio Oka
    Hiroshi Soda
    Akitoshi Kinoshita
    Masaaki Fukuda
    Seiji Nagashima
    Mutsuo Kuba
    Hiroshi Takatani
    Junji Tsurutani
    Yoichi Nakamura
    Takashi Kasai
    Yuichi Inoue
    Yoshifumi Soejima
    Shigeru Kohno
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 573 - 577
  • [47] PHASE-II STUDY OF CARBOPLATIN IN UNTREATED, INOPERABLE NON-SMALL-CELL LUNG-CANCER
    GATZEMEIER, U
    HECKMAYR, M
    HOSSFELD, DK
    ZSCHABER, R
    ACHTERRATH, W
    LENAZ, L
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) : 369 - 372
  • [48] Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced non-small cell lung cancer.
    Senju, Hiroaki
    Ogawara, Daiki
    Nakamura, Yoichi
    Fukuda, Minoru
    Nakatomi, Katsumi
    Gyotoku, Hiroshi
    Nakano, Hirofumi
    Yamaguchi, Hiroyuki
    Tomonaga, Nanae
    Ikeda, Takaya
    Mizoguchi, Kosuke
    Motoshima, Kohei
    Doi, Seiji
    Tsukamoto, Kazuhiro
    Kohno, Shigeru
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] A phase II study of carboplatin, etoposide and exisulind in patients with extensive stage small cell lung cancer: CALGB 30104.
    Wang, XF
    Govindan, R
    Herndon, JE
    Barrier, RC
    Watson, D
    Vokes, RFEE
    Green, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 660S - 660S
  • [50] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with extensive-stage small cell lung cancer
    Spigel, D. R.
    Hainsworth, J. D.
    Yardley, D. A.
    Burris, H. A., III
    Farley, C.
    Zubkus, J.
    Meng, C.
    Murphy, P.
    Saez, R.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345